Galderma Pharma, S.A., dominated the Global Topical Drug Delivery Market accounting for a highest market share in 2016, followed by Bayer AG, and Valeant Pharmaceuticals.

Pune, India -- (SBWire) -- 04/06/2018 --According to the report, the Global Topical Drug Delivery Market is expected to keep rising at a substantial rate throughout the forecast period owing to the massive influx of trade and favorable conditions in the market. This is expected to keep boosting the Global Topical Drug Delivery Market through the period as international trade is picking up, along with lots of SMEs venturing into the Global Topical Drug Delivery Market.

Request for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-topical-drug-delivery-market

Global Topical Drug Delivery Market is expected to reach USD 205.1 billion by 2024 from USD 101.7 billion in 2016, growing at a CAGR of 9.2% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

This report consists of below pages:

- No of pages: 246
- No of Figures: 17
- No of Tables: 271

Drivers included Topical Drug Delivery Market:

Some of the major factors driving the topical drug delivery market are ability to deliver drug at the desired site, inter-and intra-patient variations, without fluctuations in drug levels, an enhanced suitability for self-medication and improved compliance. Also, increasing aging population, growing prevalence of skin related ailments and rising prevalence of chronic diseases, also new and better technologies for topical drug delivery is expected to boost the growth of this market are the major factors driving the growth of the injectable drug delivery market.

Rising Cases of Acute and Chronic Diseases

The prevalence of diseases and conditions such as infections which includes bacterial infection and fungal infections, inflammations, pain management, acne, sun burns, psoriasis, dermatitis, skin allergy, skin cancer, diabetes, and many others has increased considerably over a period of time.

Rising Aging Population

With the increasing age, the cases of acute and chronic diseases are rising. Older population is more prone to diseases such as diabetes, allergy, arthritis, infections, and dermatitis.

Technological Advancements and Innovations

With the rising prevalence of acute and chronic diseases it has become important for the drug and device manufacturers to develop advanced technologies that will provide more effective treatment for the diseases. In the few years, many developments took place for the topical drug delivery due to the rapid absorption of drugs.
Approval of New Drugs

With the increasing demand for the treatment of diseases using painless and non-invasive method the demand for topical drug delivery is increasing.

Better Opportunity in Pharmerging Markets

According to Data Bridge Market Research analysts, Japan, Europe and North America are expected to account for around 73% of total global pharmaceutical market, while the rest of the world only own 27% of the market.

Inquiry about this Report visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-topical-drug-delivery-market

Major Key Players:

- Galderma Pharma, S.A.,
- Allergen Plc. Kaken Pharmaceuticals, Co., Ltd,
- Pfizer,
- Bayer AG,
- 3M,
- Hisamitsu Pharmaceuticals, Co., Inc.,
- Abbvie, Inc.,
- Valeant Pharmaceuticals,
- Antares Pharma
- Among others.

Scope of the Report:

The Global Topical Drug Delivery Market is segmented on the basis of product type, indication, distribution channel, end user and geography.

On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations. Topical drug delivery formulations are further segmented based on form into solid, semi-solid and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels and pastes. The solid drugs segment is further segmented into powders and suppositories. The liquid drugs segment is further classified into solutions and suspensions. The transdermal drug delivery devices market segment is further segmented into patches and gels.

The topical drug delivery market is segmented on the basis of indications into 4 types such as acne, anesthetics, psoriasis, dermatitis & atopic dermatitis, rosacea, onychomycosis, alopecia, actinic keratosis, and others. In 2017, anti-acne is expected to dominate the market with the highest market share in the forecast period 2017 to 2024.

On the basis of end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others. In 2017, the hospitals segment is expected to dominate the global topical drug delivery devices market with more than 40% market share.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

Read more about this Report visit @ http://databridgemarketresearch.com/reports/global-topical-drug-delivery-market/

Table of Contents:

1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
5. EXECUTIVE SUMMARY
6. TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
7. TOPICAL DRUG DELIVERY MARKET, BY END-USER
8. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
9. TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10. TOPICAL DRUG DELIVERY MARKET: COMPETITIVE LANDSCAPE
11. TOPICAL DRUG DELIVERY MARKET, COMPANY PROFILES
11.1. JANSSEN PHARMACEUTICALS, INC. (A J&J COMPANY)
11.2. CRESCITA THERAPEUTICS
11.3. GALDERMA S.A.
11.4. BIOFARMITALIA S.R.L
11.5. PHARMATEK LABORATORIES, INC.
11.6. STIEFEL LABORATORIES, INC.
11.7. TAPEMARK
11.8. NITTO DENKO CORPORATION
11.9. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
11.9. MYLAN PHARMACEUTICALS INC.
11.9. HISAMITSU PHARMACEUTICAL CO., INC.
11.10. THERASOLVE NV.
11.11. SAMYANG BIOPHARMACEUTICALS CORPORATION
11.12. LOHMANN THERAPIE-SYSTEME AG
11.13. PROSOLLUS PHARMACEUTICALS
11.14. EASTON PHARMACEUTICALS INC.
11.15. ANTARES PHARMA, INC.
11.16. ENDO PHARMACEUTICALS INC.
11.17. TRANSDERMAL TECHNOLOGIES, INC.
11.18. SHEFFIELD PHARMACEUTICALS, INC.
11.19. SOLVAY
11.20. 3M DRUG DELIVERY SYSTEMS

Related Report

North America Contraceptive Devices Market – Industry Trends and Forecast to 2024

North America Contraceptive Devices Market, By Product Type, By End-User, By Distribution Channel, By Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/north-america-contraceptive-devices-market/

About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact:

Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com